65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79723D0120
- Awardee
-
TG Therapeutics Inc. UEI JKPZKD19WMD7
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 65IB Solicitation number
- Last date to order 69% complete
- IDV ceiling
- $250,000.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
TG Therapeutics Inc. holds a Federal Supply Schedule contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian component of the Department of Veterans Affairs, to supply drugs, pharmaceuticals, and hematology-related products under General Services Administration Schedule 65 IB. This multiple award indefinite delivery vehicle, established on May 15, 2023, carries a ceiling value of $250,000 and extends through May 14, 2028. The contract operates under the parent GSA Pharmaceuticals and Drugs schedule without any set-aside restrictions, enabling TG Therapeutics to fulfill orders for Schedule 65 IB medical commodities across VISN 12 healthcare facilities. As a biopharmaceutical company specializing in treatments for blood cancers and autoimmune disorders, TG Therapeutics provides hematology-focused pharmaceuticals and related medical supplies that support the clinical needs of veterans served through the VA's integrated service network.
The contract structure allows for task orders to be placed against the established ceiling as procurement needs arise within VISN 12 medical centers. While specific task orders and pricing schedules are not detailed in the contract documentation provided, the Federal Supply Schedule mechanism enables the VA to access TG Therapeutics' approved pharmaceutical offerings on an as-needed basis throughout the performance period. This arrangement facilitates the delivery of specialized hematology treatments and related pharmaceutical products to veteran populations, leveraging the established pricing and terms negotiated under the GSA schedule framework to ensure efficient procurement of these critical medical commodities.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Vendor Address Change | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36F79723D0120?
36F79723D0120 was awarded to TG Therapeutics Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on May 15, 2023.
How much is contract 36F79723D0120 worth?
36F79723D0120's own ceiling is $250,000.
Who can order from contract 36F79723D0120?
36F79723D0120 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79723D0120 part of a contract vehicle?
Yes. 36F79723D0120 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79723D0120 competed?
The extent of competition for 36F79723D0120 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV